Focus Partners Wealth
SGMO

Focus Partners Wealth’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Focus Partners Wealth’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.72K Hold
11,000
– – ﹤0.01% 2640
2025
Q4 		$4.62K Sell
11,000
-5,300
-33% -$2.81K ﹤0.01% 2645
2025
Q3 		$10.8K Buy
16,300
+1,000
+7% +$539 ﹤0.01% 2196
2025
Q2 		$8.28K Buy
15,300
+1,000
+7% +$594 ﹤0.01% 2025
2025
Q1 		$9.38K Sell
14,300
-900
-6% -$953 ﹤0.01% 1887
2024
Q4 		$15.5K Buy
+15,200
New +$27.8K ﹤0.01% 1856

Other funds holding SGMO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Focus Partners Wealth's SGMO Position: Q1 2026 in Review

Focus Partners Wealth held its SANGAMO THERAPEUTICS INC (SGMO) position steady in Q1 2026 at 11,000 shares worth $2.72K. The position accounts for ﹤0.01% of the portfolio, ranked #2640.

Focus Partners Wealth first reported a position in SGMO in Q4 2024 and has held it in 6 quarters since. The position peaked at $15.5K in Q4 2024. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

  • Focus Partners Wealth held 11,000 shares of SANGAMO THERAPEUTICS INC worth $2.72K as of Q1 2026.
  • Focus Partners Wealth left its SANGAMO THERAPEUTICS INC share count unchanged in Q1 2026.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Focus Partners Wealth's portfolio in Q1 2026, its #2640 holding.
  • Focus Partners Wealth first reported a position in SANGAMO THERAPEUTICS INC in Q4 2024 and has held it in 6 quarters since.
  • Focus Partners Wealth's SANGAMO THERAPEUTICS INC position peaked at $15.5K in Q4 2024.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.